Newly buried body found naked beside grave

THE cadaver of a 63-year-old woman was dug up by still unidentified persons in Kabankalan City, Negros Occidental.The body was missing its clothes, which led police to believe that it was sexually molested.Lieutenant Colonel Raymond Cruz, chief of the Kabankalan City Police Station, said the incident was discovered Monday morning, August 29, 2022.Cruz said the […]

EXPLAINER: Special coordinating body for Mega/Metro Cebu in separate bills of Cutie del Mar, Edu Rama. Who will lead? Legislated rules may remove old roadblock: Cebu City feeling superior to other LGUs.

TWO BILLS, SAME SUBJECT. House Bill (HB) 00961 was filed last June 30 by Representative Marguerite Rachel “Cutie” Del Mar (BOPK) of Cebu City’s north district. It was actually the fourth filing, since the same bill was filed by her father, the late congressman Raul Del Mar, in the past three terms, the 16th, the […]

Lim: No right

People are dying. So, no, I don’t want to hear your flawed arguments about your body and your right to do with it as you wish. On all other matters, I would probably agree with you in this regard. But not on this. Not on protecting the vulnerable. Not on stopping preventable deaths. Not on […]

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan

TOKYO, Apr 23, 2021 – (JCN Newswire via – Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today an application submission in Japan for the additional indication of Eisai’s in-house discovered and developed multiple receptor tyrosine […]

Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for Uterine Body Cancer

TOKYO, Mar 12, 2021 – (JCN Newswire via – Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indication for uterine body cancer, by the Ministry of Health, Labour and Welfare (MHLW). […]